Apr

2011

DBV Technologies, SA: Series C $25.5M

Posted in I - Series C, Q - 1Q11, R - INTERNATIONAL, X - Device (Delivery), X - Drug:Device Combo, X - Immunology

DBV Technologies (France) a clinical-stage drug:device biopharma company focused on non invasive immunotherapy delivery for food allergies, closed a $25.5M Series C financing. Participants include InnoBio Fund, Lundbeckfond Ventures, ALTO Invest, Sofinnova Partners, ALK Abello and Apax Partners.

Apr

2011

Civitas Therapeutics, Inc.: Series A $20M

Posted in I - Series A, Q - 1Q11, R - NORTH EAST, X - Device (Delivery), X - Drug:Device Combo, X - Parkinson's, XX - MA

Civitas Therapeutics (Chelsea, MA) a preclinical-stage dry powder pulmonary delivery platform and device combination company focused on for Parkinson’s disease, closed a $20M Series A financing. Participants include Longitude Capital and Canaan Partners.

Dec

2010

Tyrx, Inc.: Series C $16M

Posted in I - Series C, Q - 4Q10, R - NORTH EAST, X - Antibacterial, X - Device (Cardiology), X - Drug:Device Combo, XX - NJ

Tyrx (Monmouth Junction, NJ) a commercial-stage drug:device combo company focused on a dissolving antibacterial biocompatible mesh envelope to house implanted devices such as pacemakers and defibrillators, closed a $16M Series C financing. Participants include HLM Venture Partners, Clarus Ventures and Pappas Ventures.

Aug

2010

Great Lakes Pharmaceuticals, Inc.: Series B $3.1M

Posted in I - Series B, Q - 3Q10, R - MID WEST, X - Antibacterial, X - Device (Catheter), X - Drug:Device Combo, XX - OH

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Jul

2010

Agile Therapeutics, Inc.: Series B $45M

Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Contraception, X - Drug:Device Combo, XX - NJ

Agile Therapeutics (Princeton, NJ) a clinical-stage pharmaceutical company focused on hormonal contraception, closed a $45M Series B financing. Participants include Investor Growth Capital, Care Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

Jun

2010

Incline Therapeutics, Inc.: Series A $43M

Posted in I - Series A, Q - 2Q10, R - WEST, X - Drug:Device Combo, X - Pain, XX - CA

Incline Therapeutics (Redwood City, WA) a clinical-stage drug:device combo company focused on pain, closed a $43M Series A financing. Participants include Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital Partners and Emergent Medical Partners.

Feb

2010

Zogenix, Inc.: Series B $20M

Posted in I - Series B, Q - 4Q09, R - WEST, X - Device (Delivery), X - Drug:Device Combo, XX - CA

Zogenix (San Diego, CA) a clinical-stage drug:device company focused on a needle-free delivery system of chronic pain therapeutics, closed a $20M Series B financing, bringing the total round to $71M. Participants have included Chicago Growth Partners, Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas McNerney & Partners, Oxford Finance and Abingworth Management.
Note: 2009 Year-in-Review Trend [...]

Oct

2009

Zogenix, Inc.: Series B $36M

Posted in I - Series B, Q - 3Q09, R - WEST, X - Device (Delivery), X - Drug:Device Combo, X - Pain, XX - CA

Zogenix (San Diego, CA) a clinical-stage drug:device company focused on a needle-free delivery system of chronic pain therapeutic, closed a $51M Series B financing. Participants include Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Oxford Finance and Abingworth Management.

Jul

2009

Taris Biomedical, Inc.: Series A $15M

Posted in I - Series A, Q - 2Q09, R - NORTH EAST, X - Drug:Device Combo, X - Interstitial Cystitis, XX - MA

Taris Biomedical (Lexington, MA) a preclinical-stage drug:device company focused on interstitial cystitis, close a $15M Series A financing. Participants include Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.

Nov

2008

CoAxia, Inc.: Series C $11.5M

Posted in I - Series C, Q - 2Q08, R - MID WEST, X - Device (Catheter), X - Drug:Device Combo, X - Ischemia

CoAxia (Maple Grive, MN) development-stage medical device company focused on a catheter-based therapy for cerebral ischemia, closed a $11.5M Series C financing. Participants include Canaan Partners, Prism Venture Partners, Baird Venture Partners, Affinity Capital Management, Johnson and Johnson Development Corporation and SVB Capital Partners.

Apr

2008

TyRx Pharma, Inc.: Series A $25M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - Drug:Device Combo

TyRx Pharma (Monmouth Junction, NJ) a commercialization-stage developer of implantable drug-device combination products closed a $25M Series A financing. Participants include Clarus Ventures and Pappas Ventures.

to top of page...